NVAX

NVAX: To Present At Piper Jaffray Health Care Conference @ 11:00 ET [delayed] - 12/02 - 09:26 AM ET

Novavax CEO to Present at Piper Jaffray 20th Annual Healthcare Conference - 12/01 - 08:45 AM ET

NVAX: To Present At Lazard Capital Healthcare Conference @ 15:00 ET [delayed] - 11/19 - 01:24 PM ET

Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009 - 11/13 - 12:55 PM ET

Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference - 11/12 - 08:30 AM ET

BRIEF-Novavax Q3 results - 11/10 - 08:11 AM ET

Novavax Reports Third Quarter 2008 Financial Results - 11/10 - 08:00 AM ET

NVAX: To Present At Oppenheimer Healthcare Conference @ 12:00 ET [delayed] - 11/04 - 10:23 AM ET

Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call - 11/04 - 08:00 AM ET

NVAX: To Present At BIO Investor Conference @ 11:30 ET [delayed] - 10/30 - 09:53 AM ET

Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference - 10/29 - 01:48 PM ET

Novavax CEO to Present at BIO Investor Forum 2008 - 10/28 - 02:54 PM ET

NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting - 09/29 - 12:45 PM ET

NVAX: To Present At UBS Global Life Sciences Conference @ 10:30 ET [delayed] - 09/25 - 08:53 AM ET

NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference - 09/19 - 10:33 AM ET

NVAX: Completes Enrollment for Ph IIa Trial of Seasonal Influenza VLP Vaccine - 09/19 - 08:16 AM ET

Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial - 09/19 - 08:00 AM ET

NVAX: Begins Ph II Trial for Influenza Vaccine - 09/16 - 09:12 AM ET

Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate - 09/16 - 08:22 AM ET

Novavax announces favourable results from human clinical trails in Phase 1 of pandemic influenza vaccine programme - 08/27 - 04:53 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index